Skip to Content
Merck
  • FMRP Modulates Neural Differentiation through m6A-Dependent mRNA Nuclear Export.

FMRP Modulates Neural Differentiation through m6A-Dependent mRNA Nuclear Export.

Cell reports (2019-07-25)
Brittany M Edens, Caroline Vissers, Jing Su, Saravanan Arumugam, Zhaofa Xu, Han Shi, Nimrod Miller, Francisca Rojas Ringeling, Guo-Li Ming, Chuan He, Hongjun Song, Yongchao C Ma
ABSTRACT

N6-methyladenosine (m6A) modification of mRNA is emerging as a vital mechanism regulating RNA function. Here, we show that fragile X mental retardation protein (FMRP) reads m6A to promote nuclear export of methylated mRNA targets during neural differentiation. Fmr1 knockout (KO) mice show delayed neural progenitor cell cycle progression and extended maintenance of proliferating neural progenitors into postnatal stages, phenocopying methyltransferase Mettl14 conditional KO (cKO) mice that have no m6A modification. RNA-seq and m6A-seq reveal that both Mettl14cKO and Fmr1KO lead to the nuclear retention of m6A-modified FMRP target mRNAs regulating neural differentiation, indicating that both m6A and FMRP are required for the nuclear export of methylated target mRNAs. FMRP preferentially binds m6A-modified RNAs to facilitate their nuclear export through CRM1. The nuclear retention defect can be mitigated by wild-type but not nuclear export-deficient FMRP, establishing a critical role for FMRP in mediating m6A-dependent mRNA nuclear export during neural differentiation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Delta-like protein 1 Antibody, clone PGPM-1F9, clone PGPM-1F9, from rat